U.S. Markets open in 1 hr 47 mins
  • S&P Futures

    4,407.00
    +58.00 (+1.33%)
     
  • Dow Futures

    34,503.00
    +318.00 (+0.93%)
     
  • Nasdaq Futures

    14,395.75
    +255.00 (+1.80%)
     
  • Russell 2000 Futures

    2,033.60
    +32.30 (+1.61%)
     
  • Crude Oil

    86.42
    +0.82 (+0.96%)
     
  • Gold

    1,845.90
    -6.60 (-0.36%)
     
  • Silver

    23.95
    +0.06 (+0.25%)
     
  • EUR/USD

    1.1283
    -0.0023 (-0.2031%)
     
  • 10-Yr Bond

    1.7830
    0.0000 (0.00%)
     
  • Vix

    28.75
    -0.10 (-0.35%)
     
  • GBP/USD

    1.3512
    +0.0006 (+0.0473%)
     
  • USD/JPY

    114.1820
    +0.3160 (+0.2775%)
     
  • BTC-USD

    37,925.81
    +1,376.08 (+3.76%)
     
  • CMC Crypto 200

    866.29
    +55.69 (+6.87%)
     
  • FTSE 100

    7,500.34
    +128.88 (+1.75%)
     
  • Nikkei 225

    27,011.33
    -120.01 (-0.44%)
     

LFMD, FUV & ACAD Class Action Reminders: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Investors to Contact the Firm

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • FUV
  • ACAD
  • LFMD

NEW YORK, May 19, 2021 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

LifeMD, Inc. (NASDAQ: LFMD)
Class Period: January 19, 2021 - April 13, 2021
Deadline: June 15, 2021
For more info: www.bgandg.com/lfmd.
The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and failed to disclose that: (1) many of LifeMD's executives were associated with Redwood Scientific when it was charged for unlawful autoshipping, abusive telemarketing, and false claims, and that they employed similar practices at the Company; (2) LifeMD engaged in autoshipping products to unwilling customers to record recurring revenue and the Company made it difficult to cancel such subscriptions; (3) certain of the purportedly licensed physicians on the Company's platform were not in fact licensed and faced disciplinary action; (4) as a result of the foregoing practices, the Company was reasonably likely to face regulatory scrutiny and/or reputational harm; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Arcimoto, Inc. (NASDAQ: FUV)
Class Period: February 14, 2018 - March 22, 2021
Deadline: June 18, 2021
For more info: www.bgandg.com/fuv.
The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and failed to disclose that: (1) the preorders of Arcimoto's Fun Utility Vehicles ("FUVs") were fabricated or never completed, with only 19 units delivered out of an alleged preorder of 422; (2) Arcimoto failed to disclose to customers that nearly 100% of its vehicles delivered were under safety recall; (3) Arcimoto's largest customer, R-Key-Moto, was an undisclosed related party owned by insider FOD Capital, LLC; (4) Arcimoto's partnership with HULA was an undisclosed related party transaction; and (5) as a result, defendants' public statements were materially false and/or misleading at all relevant times.

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD)
Class Period: June 15, 2020 - April 4, 2021
Deadline: June 18, 2021
For more info: www.bgandg.com/acad.
The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and failed to disclose that: (1) the materials submitted in support of the pimavanserin sNDA contained statistical and design deficiencies; (2) accordingly, the pimavanserin sNDA lacked the evidentiary support that the Company had led investors to believe it possessed; (3) the FDA was unlikely to approve the pimavanserin sNDA in its present form; and (4) as a result, the Company's public statements were materially false and misleading at all relevant times.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com